Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Eur Urol. 2023 Jun 29;84(3):331–340. doi: 10.1016/j.eururo.2023.05.031

Fig. 2 – Estimates of associations between time-to-event early and definitive endpoints. Spearman’s rank correlation coefficients for (A) OS, (B) MFS, and (C) PCSS with variations of EFS-based points.

Fig. 2 –

CI = confidence interval; DFS = disease-free survival; EFS = event-free survival; MFS = metastasis-free survival; OS = overall survival; PCSS = prostate cancer-specific survival; PSA = prostate-specific antigen.